BioMed Realty Trust, Inc. (BMR) Misses Q4 EPS by 1c

BioMed Realty Trust, Inc. (NYSE: BMR) reported Q4 EPS of $0.28, $0.01 worse than the analyst estimate of $0.29. Revenue for the quarter came in at $112.4 million versus the consensus estimate of $112.02 million.

For earnings history and earnings-related data on BioMed Realty Trust, Inc. (BMR) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Star Equity Holdings (STRR) Misses Q2 EPS by 8c
• Tenon Medical (TNON) Misses Q2 EPS by 395c
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c